These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3987548

  • 1. Renal effects of felodipine in hypertensive patients with reduced renal function.
    Herlitz H, Aurell M, Björck S, Granérus G.
    Drugs; 1985; 29 Suppl 2():192-7. PubMed ID: 3987548
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of felodipine in patients with refractory hypertension.
    Herlitz H, Björck S, Nyberg G, Granérus G, Aurell M.
    Drugs; 1987; 34 Suppl 3():151-5. PubMed ID: 3443059
    [Abstract] [Full Text] [Related]

  • 3. Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
    Andersson OK, Granérus G, Hedner T.
    Drugs; 1985; 29 Suppl 2():102-8. PubMed ID: 3886356
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of felodipine on blood pressure and renal hemodynamics in severe hypertension.
    Herlitz H, Granérus G, Aurell M.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S100-2. PubMed ID: 1693710
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of felodipine in patients with reduced renal function.
    Herlitz H.
    Kidney Int Suppl; 1992 May; 36():S110-3. PubMed ID: 1614060
    [Abstract] [Full Text] [Related]

  • 6. Comparative trial of felodipine and nifedipine in refractory hypertension.
    Aberg H, Lindsjö M, Mörlin B.
    Drugs; 1985 May; 29 Suppl 2():117-23. PubMed ID: 3886357
    [Abstract] [Full Text] [Related]

  • 7. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
    Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1984 May; 6(3):392-8. PubMed ID: 6202963
    [Abstract] [Full Text] [Related]

  • 8. Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
    Andersson OK, Hedner T, Granérus G.
    Drugs; 1987 May; 34 Suppl 3():156-60. PubMed ID: 2894974
    [Abstract] [Full Text] [Related]

  • 9. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension.
    Collste P, Danielsson M, Elmfeldt D, Feleke E, Gelin A, Hedner T, Rydén L.
    Drugs; 1985 May; 29 Suppl 2():124-30. PubMed ID: 2859184
    [Abstract] [Full Text] [Related]

  • 10. Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.
    Larsson R, Karlberg BE, Gelin A, Aberg J, Regårdh CG.
    J Clin Pharmacol; 1990 Nov; 30(11):1020-30. PubMed ID: 2243149
    [Abstract] [Full Text] [Related]

  • 11. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987 Nov; 34 Suppl 3():139-48. PubMed ID: 2894973
    [Abstract] [Full Text] [Related]

  • 12. Felodipine compared to nifedipine as "third-line drug" in resistant hypertension.
    Maclean D, Mitchell ET, Readman AS.
    Angiology; 1986 Nov; 37(11):840-5. PubMed ID: 3789464
    [Abstract] [Full Text] [Related]

  • 13. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A, Ljungman S, Hartford M, Wikstrand J.
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive effect of felodipine combined with beta-blockade. A comparison between 2 and 3 daily dosages.
    Hansson BG, Lyngstam G, Lyngstam O, Rydén L, Thilén U.
    Drugs; 1985 Feb; 29 Suppl 2():131-6. PubMed ID: 2859185
    [Abstract] [Full Text] [Related]

  • 15. Felodipine in the treatment of patients with severe hypertension and impaired renal function.
    Larsson R, Lindsjö MK, Danielsson B, Bengtsson U, Hardlund JH, Sjöström PA, Elmfeldt D, Moberg L.
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):253-9. PubMed ID: 2285618
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [Abstract] [Full Text] [Related]

  • 17. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Br J Clin Pharmacol; 1986 Jun; 21(6):633-40. PubMed ID: 3527242
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG, Leenen FH, Tanner J.
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [Abstract] [Full Text] [Related]

  • 19. A parallel group randomised comparative study of felodipine and nifedipine in hypertension.
    Sharma SM, Sethi KK, Kaul UA, Arora R, Khalilullah M.
    Indian Heart J; 1991 Jul; 43(3):171-3. PubMed ID: 1800302
    [Abstract] [Full Text] [Related]

  • 20. Effects of felodipine on renal function in animals.
    DiBona GF.
    Drugs; 1985 Jul; 29 Suppl 2():168-75. PubMed ID: 3987545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.